Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 44151-44200 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05699330
Subgenual Cingulate Deep Brain STIMulation for Apathetic Behavioral Variant FRONtotemporal Dementia
NARecruiting
6 participants
Started: Jan 12, 2023 · Completed: Jan 12, 2026
2 conditions2 sponsors1 location
NCT05649345
TR64 in Patients With Advanced Solid Tumors
PHASE1Recruiting
19 participants
Started: Jan 12, 2023 · Completed: Dec 30, 2026
1 condition1 sponsor2 locations
NCT06696885
Mobile Applications for Exercise Adherence and Hand Function in Chronic Stroke.
NARecruiting
32 participants
Started: Jan 12, 2023 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT05745805
Cohort Follow-up of Epidemic and Neuroimaging for Patients During the 1st Wave of the COVID-19 in China
N/ARecruiting
600 participants
Started: Jan 12, 2023 · Completed: Sep 12, 2026
4 conditions9 sponsors1 location
NCT05278520
Complex Molecular Etiology and Cellular Landscape of Hip Osteoarthritis
N/ARecruiting
110 participants
Started: Jan 11, 2023 · Completed: Dec 31, 2028
2 conditions3 sponsors4 locations
NCT05526560
Real-world Clinical Outcomes of the MITRIS RESILIA Mitral Valve
N/ARecruiting
500 participants
Started: Jan 11, 2023 · Completed: Dec 31, 2035
2 conditions1 sponsor37 locations
NCT04436978
What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?
PHASE4Recruiting
2,000 participants
Started: Jan 11, 2023 · Completed: Dec 1, 2027
11 conditions2 sponsors20 locations
NCT06927349
A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1301 in Advanced Solid Tumors.
PHASE1Recruiting
70 participants
Started: Jan 11, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05633511
Changes of Soft Tissue Grafting: A Randomized Study
NARecruiting
50 participants
Started: Jan 11, 2023 · Completed: Dec 30, 2036
1 condition1 sponsor1 location
NCT06157008
Brain Network Analysis of Anesthesia Characteristics in Patients With pDoC Based on PSG
N/ARecruiting
60 participants
Started: Jan 11, 2023 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT05386342
A PMCF Study Confirm the Performance and Safety of the TufTex Over-the-Wire (OTW) Embolectomy Catheters
NARecruiting
112 participants
Started: Jan 11, 2023 · Completed: Jun 30, 2027
3 conditions2 sponsors3 locations
NCT05615974
A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors
PHASE1/PHASE2Recruiting
139 participants
Started: Jan 11, 2023 · Completed: Jan 11, 2028
1 condition1 sponsor5 locations
NCT05773651
Rare Tumours in Children and Adolescents (STEP)
N/ARecruiting
10,000 participants
Started: Jan 11, 2023 · Completed: Jan 31, 2055
1 condition1 sponsor1 location
NCT05727930
Variable Intensive Early Walking Post-Stroke - 2 (VIEWS-2)
NARecruiting
100 participants
Started: Jan 11, 2023 · Completed: Oct 15, 2028
1 condition3 sponsors1 location
NCT06838702
Structured Data Collection of Patients Undergoing Liver Transplantation and Evaluated for Bone Mineral Metabolism
N/ARecruiting
150 participants
Started: Jan 11, 2023 · Completed: Jan 11, 2028
2 conditions1 sponsor1 location
NCT06094036
Physical Exercise as a Sustainability Tool in Men With Dysmetabolic Hypogonadism
NARecruiting
72 participants
Started: Jan 11, 2023 · Completed: Dec 31, 2024
5 conditions1 sponsor1 location
NCT05555732
Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)
PHASE3Recruiting
1,170 participants
Started: Jan 11, 2023 · Completed: Aug 1, 2027
1 condition3 sponsors252 locations
NCT05598151
Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors
PHASE1Recruiting
170 participants
Started: Jan 11, 2023 · Completed: Jun 30, 2028
1 condition1 sponsor10 locations
NCT05588154
Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
N/ARecruiting
1,000 participants
Started: Jan 11, 2023 · Completed: Dec 1, 2052
1 condition1 sponsor1 location
NCT06292741
Autonomic Involvement in Patient With Cognitive Decline
NARecruiting
120 participants
Started: Jan 11, 2023 · Completed: Jan 31, 2026
2 conditions1 sponsor1 location
NCT05665504
Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer
N/ARecruiting
250 participants
Started: Jan 11, 2023 · Completed: Feb 29, 2028
2 conditions1 sponsor1 location
NCT05337722
App for Pregnancy Smoking Cessation With Peer Support
NARecruiting
790 participants
Started: Jan 11, 2023 · Completed: Aug 31, 2025
2 conditions4 sponsors1 location
NCT05573126
Phase 1/2 Study to Evaluate Vosilasarm (EP0062) as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
PHASE1/PHASE2Recruiting
60 participants
Started: Jan 11, 2023 · Completed: Nov 30, 2026
3 conditions1 sponsor14 locations
NCT05997992
Clinical Efficacy Evaluation of Electroacupuncture as Adjuvant Therapy for Female Patients With Overactive Bladder
NARecruiting
100 participants
Started: Jan 11, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05527184
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers
PHASE1Recruiting
423 participants
Started: Jan 11, 2023 · Completed: Feb 28, 2027
5 conditions1 sponsor51 locations
NCT05676242
A Phase III Extended Clinical Trial of Jaktinib Hydrochloride Tablets in the Treatment of Moderate and Severe Atopic Dermatitis
PHASE3Recruiting
400 participants
Started: Jan 11, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor2 locations
NCT06465823
Efficacy of Bumetanide to Improve Cognitive Functions in Down Syndrome
PHASE2Recruiting
64 participants
Started: Jan 11, 2023 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT05501756
Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation
PHASE2Recruiting
60 participants
Started: Jan 11, 2023 · Completed: Aug 31, 2028
1 condition1 sponsor1 location
NCT05709106
A Prospective Real World Study of Rimegepant in the Treatment of Migraine
N/ARecruiting
100 participants
Started: Jan 11, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05982132
Weight Changes Among Martinican Prisoners
N/ARecruiting
227 participants
Started: Jan 11, 2023 · Completed: Aug 31, 2025
2 conditions1 sponsor1 location
NCT05649982
Optimization of Guidance in a Digital Tool for Problematic Alcohol Use
NARecruiting
300 participants
Started: Jan 11, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05459233
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
NARecruiting
310 participants
Started: Jan 11, 2023 · Completed: Sep 1, 2029
3 conditions1 sponsor7 locations
NCT05746442
Ending Tobacco Use Through Interactive Tailored Messaging for Cambodian People Living With HIV/AIDS
NARecruiting
800 participants
Started: Jan 11, 2023 · Completed: Feb 28, 2027
2 conditions4 sponsors3 locations
NCT05663931
Diabetes Toolkit at Discharge
NARecruiting
120 participants
Started: Jan 10, 2023 · Completed: Sep 1, 2025
2 conditions1 sponsor1 location
NCT06333093
Duodenal tIssue ResEction aCquisiTion (DIRECT) Study
NARecruiting
30 participants
Started: Jan 10, 2023 · Completed: Jun 1, 2024
1 condition1 sponsor1 location
NCT05670847
Exogenous Ketone Esters for Drug Resistant Epilepsy
PHASE2/PHASE3Recruiting
60 participants
Started: Jan 10, 2023 · Completed: Jul 1, 2025
1 condition1 sponsor1 location
NCT05689112
Microscopy Imaging of Whole-mount Stained Human Tissues
N/ARecruiting
250 participants
Started: Jan 10, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05990686
Paracetamol Plus Tramadol Versus Fentanyl in Day Case Surgeries
N/ARecruiting
132 participants
Started: Jan 10, 2023 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT05638113
Prolonged Air Leakage After Major Lung Resection
NARecruiting
182 participants
Started: Jan 10, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05664945
Rethinking Pulmonary Rehabilitation - a Three-arm Randomised Multicentre Trial
NARecruiting
180 participants
Started: Jan 10, 2023 · Completed: Jul 31, 2026
1 condition4 sponsors7 locations
NCT05482711
The Fuel and Rhythm (FAR) Phase 2 Study
NARecruiting
15 participants
Started: Jan 10, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05554302
Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis
PHASE2Recruiting
20 participants
Started: Jan 10, 2023 · Completed: Jan 31, 2030
2 conditions2 sponsors1 location
NCT04216927
NO During CPB in Neonates to Reduce Risk of AKI
PHASE3Recruiting
40 participants
Started: Jan 10, 2023 · Completed: Jun 30, 2026
3 conditions3 sponsors1 location
NCT04945213
Biperiden Trial for Epilepsy Prevention
PHASE3Recruiting
312 participants
Started: Jan 10, 2023 · Completed: Dec 20, 2026
3 conditions11 sponsors10 locations
NCT05519189
Evaluation of the Value of Perianal Infiltration During Thermodestruction of Haemorrhoidal Disease by Radiofrequency
PHASE4Recruiting
134 participants
Started: Jan 10, 2023 · Completed: Feb 28, 2026
1 condition1 sponsor3 locations
NCT05657197
The Effect of Intensive Physical Exercise on Fatigue and Quality of Life in Patients With Quiescent Inflammatory Bowel Disease
NARecruiting
100 participants
Started: Jan 10, 2023 · Completed: Dec 31, 2025
1 condition5 sponsors3 locations
NCT03760575
Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)
PHASE1Recruiting
20 participants
Started: Jan 10, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05567133
Risk Indicators of Sarcoidosis Evolution-Unified Protocol
N/ARecruiting
200 participants
Started: Jan 10, 2023 · Completed: Mar 30, 2026
1 condition4 sponsors2 locations
NCT05758493
Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
PHASE2Recruiting
150 participants
Started: Jan 10, 2023 · Completed: Mar 10, 2028
2 conditions2 sponsors1 location
NCT05158894
Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy
N/ARecruiting
1,884 participants
Started: Jan 10, 2023 · Completed: Sep 30, 2034
1 condition1 sponsor1 location